Randomized Clinical News Today

Urolithin A is a metabolite with profound health benefits and potential longevity effects.

Study highlights the importance of early interventions for institutionalized children.

Study found that combining behavioral text messages with financial incentives promotes significant weight loss in obese men, while text messages alone do not.

Dr Ray O’Connor takes a look at the latest clinical studies on physical activity

NCI sponsored, ECOG-ACRIN Phase 3 Study of Leukine in Combination with Ipilimumab and Nivolumab in Front Line Treatment of Melanoma Heads to Last Stages of Enrollment

As sustainability awareness grows and omega-3 demand rises, krill oil stands out as a sustainable and stable alternative.

Ubiquinol supplementation can be an effective way to promote healthy aging and protect the body from oxidative stress.

Psychedelic medicines such as psilocybin, MDMA, ketamine, and LSD have been shown to have a significant impact on conditions such as major depressive disorder, generalized anxiety disorder, and post-traumatic stress disorder in clinical trials.

Aspirin, known as acetylsalicylic acid, has been marketed in ways that have de-emphasized potential risks to children.

Nearly a decade after becoming the first PCSK9 inhibitor to receive approval from the FDA, alirocumab (Praluent) has now received approval for pediatric patients with HeFH based on data from a phase 3 trial.